Astrana Health, Inc. (ASTH)
NASDAQ: ASTH · Real-Time Price · USD
29.69
+0.59 (2.03%)
Aug 13, 2025, 4:00 PM - Market closed
Astrana Health Stock Forecast
Stock Price Forecast
According to 7 professional analysts, the 12-month price target for Astrana Health stock ranges from a low of $36 to a high of $70. The average analyst price target of $53.29 forecasts a 79.49% increase in the stock price over the next year.
Price Target: $53.29 (+79.49%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 1, 2025.
Analyst Ratings
The average analyst rating for Astrana Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold Initiates $36 | Hold | Initiates | $36 | +21.25% | Apr 1, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $50 → $46 | Strong Buy | Maintains | $50 → $46 | +54.93% | Mar 18, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $55 → $49 | Strong Buy | Maintains | $55 → $49 | +65.04% | Mar 4, 2025 |
| Baird | Baird | Buy Maintains $86 → $50 | Buy | Maintains | $86 → $50 | +68.41% | Mar 3, 2025 |
| Stifel | Stifel | Strong Buy Maintains $70 → $56 | Strong Buy | Maintains | $70 → $56 | +88.62% | Feb 20, 2025 |
Financial Forecast
Revenue This Year
2.97B
from 2.03B
Increased by 46.18%
Revenue Next Year
3.69B
from 2.97B
Increased by 23.94%
EPS This Year
1.22
from 0.90
Increased by 35.36%
EPS Next Year
1.70
from 1.22
Increased by 39.77%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.4B | 4.4B | 4.7B | ||
| Avg | 3.0B | 3.7B | 4.2B | ||
| Low | 2.5B | 2.8B | 3.4B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 67.7% | 48.1% | 28.8% | ||
| Avg | 46.2% | 23.9% | 14.4% | ||
| Low | 23.8% | -5.8% | -8.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1.67 | 2.73 | 3.39 |
| Avg | 1.22 | 1.70 | 2.43 |
| Low | 0.80 | 0.33 | 0.90 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 85.5% | 124.1% | 99.4% |
| Avg | 35.4% | 39.8% | 42.8% |
| Low | -10.7% | -72.8% | -47.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.